These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2561573)

  • 21. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of mutants in polio vaccine viruses using pooled antipoliovirus monoclonal antibodies.
    Horie H; Sato-Miyazawa M; Ota Y; Wakabayashi K; Doi T; Yoshizawa K; Doi Y; Hashizume S
    Biologicals; 1999 Sep; 27(3):217-26. PubMed ID: 10652177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
    Uhlig H; Rutter G; Dernick R
    Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poliovirus-binding inhibition ELISA for evaluation of immune response to oral poliovirus vaccine: a possible alternative to the neutralization test.
    Ivanov AP; Dragunsky EM; Ivanova OE; Rezapkin GV; Potapova SG; Chumakov KM
    Hum Vaccin; 2005; 1(3):102-5. PubMed ID: 17012865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of antigenic properties of vaccine derived poliovirus strains.
    Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
    Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparison of the diagnostic value of the virus neutralization reaction and of indirect immunoenzyme analysis using monoclonal antibodies for the intratype differentiation of vaccinal and virulent poliovirus strains].
    Nikolaienko IV
    Lik Sprava; 1998 May; (3):84-6. PubMed ID: 9695574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
    Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
    J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
    Crainic R; Blondel B; Aubert-Combiescu A; Beytout D; Couillin P; Candrea A; Boué A; Horaud F
    Dev Biol Stand; 1984; 57():165-70. PubMed ID: 6084607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073.
    Kouiavskaia DV; Dragunsky EM; Liu HM; Oberste MS; Collett MS; Chumakov KM
    Antivir Ther; 2011; 16(7):999-1004. PubMed ID: 22024515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic structure of chimeras of type 1 and type 3 poliovirus involving antigenic site 1.
    Minor PD; Ferguson M; Katrak K; Wood D; John A; Howlett J; Dunn G; Burke K; Almond JW
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2543-51. PubMed ID: 1701474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
    Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved distribution of antigenic site specificity of poliovirus-neutralizing antibodies induced by a protease-cleaved immunogen in mice.
    Roivainen M; Montagnon B; Chalumeau H; Murray M; Wimmer E; Hovi T
    J Virol; 1990 Feb; 64(2):559-62. PubMed ID: 1688625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary studies on antigenic variation of poliovirus using neutralizing monoclonal antibodies.
    Guo R; Tang EH; Wang H; Yang XF; Liu MY; Qin HX; Li QH; Zhuang JY; Liu KM
    J Gen Virol; 1987 Apr; 68 ( Pt 4)():989-94. PubMed ID: 3033136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping.
    Minor PD; Schild GC; Ferguson M; Mackay A; Magrath DI; John A; Yates JP; Spitz M
    J Gen Virol; 1982 Aug; 61 (Pt 2)():167-76. PubMed ID: 6181190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.
    Crainic R; Couillin P; Cabau N; Boue A; Horodniceanu F
    Dev Biol Stand; 1981; 50():229-34. PubMed ID: 6176486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and potential use of monoclonal antibodies against polio viruses.
    Osterhaus AD; van Wezel AL; van Steenis G; Hazendonk AG; Drost G
    Dev Biol Stand; 1981; 50():221-8. PubMed ID: 6281107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
    Thibodeau L; Lacroix M; Lecomte J; Fauvel M
    Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
    Shyrobokov VP; Kostenko IH; Nikolaienko IV
    Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen chimaeras of poliovirus as potential new vaccines.
    Burke KL; Dunn G; Ferguson M; Minor PD; Almond JW
    Nature; 1988 Mar; 332(6159):81-2. PubMed ID: 2450279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular and humoral immune responses to poliovirus in mice: a role for helper T cells in heterotypic immunity to poliovirus.
    Katrak K; Mahon BP; Minor PD; Mills KH
    J Gen Virol; 1991 May; 72 ( Pt 5)():1093-8. PubMed ID: 1851808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.